Novo Nordisk, the company that makes the drugs, reportedthat in 2022, 81% of Wegovypatients were women
With 11.2% of adults on GLP-1s, and another 8.3% considering it, CPG brands face a stealthy drop in food consumption
In a statement, Novo confirmed it did not provide any funding or sponsorship to ABC to support the broadcast, nor had any control over the programs production, content or guests
A licensed provider reviews your information, determines whether GLP-1 treatment is appropriate, and prescribes accordingly
The 0.9% benzyl alcohol preservative maintains sterility across multiple punctures for up to 28 days
These findings suggest that semaglutide protects kidney function even in people without diabetes